Small for Gestational Age Affects Outcomes on Singletons and Inborn Births in Extremely Preterm Infants: A Japanese Cohort Study
American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e780-e787
DOI: 10.1055/a-1933-4627 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Hideyo Suenaga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of pediatrics, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Gestational Age, Infant, Extremely Premature, Infant, Small for Gestational Age. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Themen: Neonatologie
Abstract (Originalsprache)
Objective
This study aimed to compare the short- and long-term outcomes of extremely preterm small for gestational age (SGA) infants and appropriate for gestational age (AGA) infants in Japan. Study Design We retrospectively assessed 434 SGA and 1,716 AGA infants born at 22 to 27 weeks of gestational age (GA) and examined their outcomes on singletons and inborn births between 2003 and 2012. Infants were followed-up for 3 years, and the clinical characteristics and outcomes were compared. Fisher's exact and Student's t-tests were used for independent sample comparison. Logistic regression was used to identify associated factors.
Results
The prevalence of intraventricular hemorrhage ≥ grade 3 was significantly lower (adjusted odds ratio [aOR]: 0.28; 95% confidence interval [CI]: 0.11 − 0.72), and the prevalence of bronchopulmonary dysplasia at 36 weeks of GA and the need for home oxygen therapy were significantly higher (aOR: 2.20; 95% CI: 1.66 − 2.91 and aOR: 2.46; 95% CI: 1.75–3.47, respectively) in SGA infants than in AGA infants. SGA infants born at 24 to 25 weeks of GA had a significantly higher prevalence of developmental quotient (DQ) < 70 (aOR: 1.73; 95% CI: 1.08 − 2.77). Those born at 26 to 27 weeks of GA showed a significantly higher prevalence of cerebral palsy (CP) and visual impairment (aOR: 2.31; 95% CI: 1.22 − 4.40 and aOR: 2.61; 95% CI: 1.21 − 5.61, respectively).
Conclusion
In SGA infants, birth at 24 to 25 weeks of GA is an independent risk factor for DQ < 70, and birth at 26 to 27 weeks of GA is an independent risk factor for CP and visual impairment. However, we did not consider nutritional and developmental factors, and a longer follow-up would help assess neurodevelopmental outcomes. Key Points
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of pediatrics, National Hospital Organization Nagasaki Medical Center, Nagasaki, Japan.
- Department of Advanced Medicine, Research and Development Center for New Medical Frontiers, Kanagawa, Japan.
- Department of Pediatrics, Tokai University School of Medicine, Kanagawa, Japan.
- Department of Pediatrics, Kyorin University, Tokyo, Japan.
ORCID-Profile: Hideyo Suenaga
Zitieren
APA
Suenaga, H., Nakanishi, H., Uchiyama, A., Kusuda, S., & Neonatal Research Network of Japan (2024). Small for Gestational Age Affects Outcomes on Singletons and Inborn Births in Extremely Preterm Infants: A Japanese Cohort Study. American Journal of Perinatology, 41(S 01 S 01), e780-e787. https://doi.org/10.1055/a-1933-4627
Vancouver
Suenaga H, Nakanishi H, Uchiyama A, Kusuda S, Neonatal Research Network of Japan. Small for Gestational Age Affects Outcomes on Singletons and Inborn Births in Extremely Preterm Infants: A Japanese Cohort Study. American Journal of Perinatology. 2024;41(S 01 S 01):e780-e787. doi:10.1055/a-1933-4627
BibTeX
@article{Suenaga2024,
author = {Suenaga, Hideyo and Nakanishi, Hidehiko and Uchiyama, Atsushi and Kusuda, Satoshi and Neonatal Research Network of Japan, Neonatal Research Network of Japan},
title = {Small for Gestational Age Affects Outcomes on Singletons and Inborn Births in Extremely Preterm Infants: A Japanese Cohort Study},
journal = {American Journal of Perinatology},
year = {2024},
volume = {41},
number = {S 01 S 01},
pages = {e780--e787},
doi = {10.1055/a-1933-4627}
}
EUVIMED